Omega Healthcare, a healthcare management servicer, has acquired Reventics, a physician-focused CDI and RCM company.Omega is backed by Goldman Sachs Asset Management‘s private equity business and Everstone Group.
Reventics is a clinical documentation improvement and revenue cycle management provider that enhances physician reimbursement and compliance while improving clinical quality measures. Omega helps payers, providers, and pharmaceutical companies by providing virtual nursing services and streamlining processes.
This acquisition enables Omega Healthcare to expand its RCM offering by leveraging Reventics’ proprietary cloud-native platforms for CDI and RCM along with expert clinical resources to drive improved outcomes for its clients. The transaction is part of Omega Healthcare’s growth plan to expand its existing CDI capabilities through technology-driven services.
“Reventics brings to our organization clinical excellence, analytic capabilities, and new age technologies to complement Omega’s existing technology and automation services,” says Anurag Mehta, CEO of Omega Healthcare. “Not only is this a strategic fit that will benefit our clients, but we will be able to expand our CDI and RCM capabilities through this acquisition while increasing our AI capabilities as well.”
KPMG Corporate Finance LLC acted as the financial advisor to Reventics on this transaction.